19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
It has become somewhat of an annual tradition in California: with every new year comes a further inc...
Read More >
In recent years, fintech has been an attractive sector for growth capital, as evidenced by robust in...
Read More >
In today’s edition of the Daily Compliance News: 1. How AB InBev uses the ‘ethical edge’. (WSJ) ...
Read More >
CSG Labor & Employment Alert - Effective July 9, 2019, employers who fail to pay prevailing wages ...
Read More >
HR Solutions Company Fired Employee Because of Mental Disabilities, Federal Agency Charges - HOUST...
Read More >
Congress Sprints to the Finish. Congress returned this week from its Thanksgiving break and is racin...
Read More >